Logo

American Heart Association

  1
  0


Final ID: TP86

Evaluating the Implementation of Brainomix 360 AI Stroke Software in a Robust Academic Hub-and-Spoke Telestroke Network

Abstract Body: Background
Artificial intelligence (AI) stroke imaging software is becoming mainstay in many hub-and-spoke hospitals. Brainomix 360 Stroke software is the market leader in Europe focused on leveraging simple imaging (non-contrast computerized topography (NCCT) and CT angiography (CTA)) and has recently been FDA-cleared for use in the USA. We evaluated the implementation of Brainomix 360 AI Stroke software in the 17 spoke, multi-state Mayo Clinic Health System (MCHS) telestroke network.

Methods
This prospective study compared decision and treatment times before and after Brainomix AI implementation, as well as clinician feedback and simulated decision making to better understand any changes seen. Patients were included if they underwent telestroke evaluation at an MCHS emergency department within 90 days of implementation (2/9/2024-8/8/2024), and excluded if they were already admitted to the hospital or if video evaluation was not performed. Data collection included demographics, clinical decisions and treatment times. Qualitative surveys were conducted at baseline and evaluation end, as well as simulated decision making in 20 de-identified cases randomized to with/without AI through an online portal.

Results
A total of 907 patients were included (444 pre- and 463 post-implementation, 287 (32%) with ischemic stroke final diagnosis). Median NIHSS was 2. IVT was recommended in 20.3% (27/148 ischemic stroke patients) pre- and 25.9% (36/139) post-implementation. EVT was recommended in 16.2% (24/148) pre and 14.4% (20/139) post. AI use was associated with trends of faster telestroke activation to IVT decision (36 vs 32 mins, p=0.6), IVT administration (47 vs 40 minutes, p=0.6), and EVT decision (36 vs 33 minutes, p=0.5). In the simulation, imaging interpretation was significantly faster when randomized to AI use (3.4 vs 2.1 mins, p<0.001) and associated with improved physician confidence (62 vs 88%, p=0.004). Qualitative feedback from 14/24 neurologists showed the greatest perceived value was improved confidence of treatment decisions (43%) and faster triaging (36%). Most value was gained from e-ASPECTS (NCCT) and LVO modules.

Conclusion
This service evaluation highlighted the opportunity to improve efficiency of decision making even in the setting of a well-developed telestroke system. The impact was underpinned by the improved speed and confidence of imaging interpretation reflected in an offline simulation and qualitative feedback.
  • Smith, Brett  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Woodhead, Zoe  ( Brainomix , Oxford , United Kingdom )
  • Harston, George  ( Oxford University Hospitals , Oxford , United Kingdom )
  • English, Stephen  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Wolfe, Jackson  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Karam, Alvina  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Demaerschalk, Bart  ( Mayo Clinic College of Medicine , Scottsdale , Arizona , United States )
  • Hrdlicka, Courtney  ( Mayo Clinic , Scottsdale , Arizona , United States )
  • Nasr, Deena  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Chukwudelunzu, Felix  ( MAYO CLINIC HEALTH SYSTEM EAU , Eau Claire , Wisconsin , United States )
  • Nord, Charisse  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Pahl, Emily  ( Mayo Clinic , Jacksonville , Florida , United States )
  • Author Disclosures:
    Brett Smith: DO NOT have relevant financial relationships | Zoe Woodhead: DO have relevant financial relationships ; Employee:Brainomix Limited:Active (exists now) | George Harston: DO have relevant financial relationships ; Employee:Brainomix:Active (exists now) | Stephen English: DO NOT have relevant financial relationships | Jackson Wolfe: DO NOT have relevant financial relationships | Alvina Karam: DO NOT have relevant financial relationships | Bart Demaerschalk: DO NOT have relevant financial relationships | Courtney Hrdlicka: DO have relevant financial relationships ; Consultant:Genomadix:Active (exists now) | Deena Nasr: DO NOT have relevant financial relationships | Felix Chukwudelunzu: DO NOT have relevant financial relationships | Charisse Nord: DO NOT have relevant financial relationships | Emily Pahl: DO NOT have relevant financial relationships
Meeting Info:
Session Info:

Cerebrovascular Systems of Care Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
An Evaluation of Vascular Neurology Fellowship Websites: How Informed an Applicant Could Be?

Sivakumar Milan, Degen Nathaniel, Varkey Thomas, Alexandrov Andrei, Singh Savdeep

Cost of Stroke Treatment: A Comparative Analysis of Mobile Stroke and Standard Treatment

Davis Nicolle, Lykens David, Khanna Anna, Jacobs Molly

More abstracts from these authors:
Impact of Artificial Intelligence Imaging Decision Support Software on Treatment of Acute Ischemic Stroke in England

Nagaratnam Kiruba, Neuhaus Ain, Epton Matthew, Marriott Tracey, Woodhead Zoe, Fernandez Claire, Ford Gary, Harston George

Using CTP based Disconnectome Mapping to identify optimal candidates for endovascular treatment in acute ischemic stroke.

Carone Davide, Garrard James, Zarrintan Armin, Brinjikji Waleed, Harston George, Kallmes David

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)